Regular salmeterol vs placebo
All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma
Regular salmeterol leads to higher all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with placebo (high certainty).
1 finding from 1 review
- Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes onlyOR 1.14 [1.01, 1.28]13 studies · 30196 participantsHigh